These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2952700)

  • 41. [Echocardiographic study of hypertrophic cardiomyopathy localized in the free wall of the left ventricle].
    Alcini E; Monticelli M; Pitasso L; Anastasi R
    G Ital Cardiol; 1983; 13(1):51-7. PubMed ID: 6683690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy.
    Maron BJ; Harding AM; Spirito P; Roberts WC; Waller BF
    Circulation; 1983 Aug; 68(2):282-93. PubMed ID: 6683131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progression of hypertrophic cardiomyopathy. A cross sectional echocardiographic study.
    Domenicucci S; Lazzeroni E; Roelandt J; ten Cate FJ; Vletter WB; Arntzenius AC; Das SK
    Br Heart J; 1985 Apr; 53(4):405-11. PubMed ID: 4039187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
    Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
    Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of two-dimensional and speckle tracking echocardiography in "Gray Zone" left ventricular hypertrophy to differentiate professional football player's heart from hypertrophic cardiomyopathy.
    Kansal MM; Lester SJ; Surapaneni P; Sengupta PP; Appleton CP; Ommen SR; Ressler SW; Hurst RT
    Am J Cardiol; 2011 Nov; 108(9):1322-6. PubMed ID: 21855830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative assessment of ultrasonic myocardial reflectivity in hypertrophic cardiomyopathy.
    Lattanzi F; Spirito P; Picano E; Mazzarisi A; Landini L; Distante A; Vecchio C; L'Abbate A
    J Am Coll Cardiol; 1991 Apr; 17(5):1085-90. PubMed ID: 1826118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy.
    Thaman R; Gimeno JR; Reith S; Esteban MT; Limongelli G; Murphy RT; Mist B; McKenna WJ; Elliott PM
    J Am Coll Cardiol; 2004 Jul; 44(2):398-405. PubMed ID: 15261938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment.
    Spirito P; Maron BJ; Rosing DR
    Circulation; 1984 Dec; 70(6):984-95. PubMed ID: 6541978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical ASH)].
    Koga Y; Takahashi H; Ifuku M; Itaya M; Adachi K; Toshima H
    J Cardiogr; 1984 Aug; 14(2):301-10. PubMed ID: 6543446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood.
    Panza JA; Maron BJ
    Am J Cardiol; 1989 May; 63(17):1258-65. PubMed ID: 2523641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypertrophic cardiomyopathy with mild left ventricular remodeling: echocardiographic assessment using left ventricular wall motion score.
    Hayato K; Okawa M; Matsumura Y; Kitaoka H; Kubo T; Hitomi N; Yamasaki N; Yabe T; Furuno T; Takata J; Nishinaga M; Doi YL
    J Cardiol; 2008 Apr; 51(2):95-105. PubMed ID: 18522782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: incidence and prognostic value.
    Hina K; Kusachi S; Iwasaki K; Nogami K; Moritani H; Kita T; Taniguchi G; Tsuji T
    Clin Cardiol; 1993 May; 16(5):403-7. PubMed ID: 8504574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Two-dimensional echocardiographic evaluation of the right ventricular wall in hypertension and hypertrophic cardiomyopathy].
    Watanabe T; Torii Y; Ochiai M; Kuribayashi T; Kitamura M; Kohno Y; Furukawa K; Matsukubo H; Katsume H; Ijichi H
    J Cardiogr; 1982 Sep; 12(3):625-34. PubMed ID: 6892223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Possibilities of echocardiographic evaluation of hemodynamic disorders in hypertrophic cardiomyopathy].
    Tendera M; Wodniecki J; Polonski L; Szczurek K; Kardaszewicz P; Wilczek K; Kozielska E; KuĊ›nierz B; Wycisk A; Wantrych M
    Kardiol Pol; 1989; 32 Suppl 1():16-22. PubMed ID: 2638428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy.
    Brown ML; Schaff HV; Dearani JA; Li Z; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):439-43. PubMed ID: 20832083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes.
    Pelliccia A; Maron BJ; Culasso F; Spataro A; Caselli G
    JAMA; 1996 Jul; 276(3):211-5. PubMed ID: 8667565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value and limitations of two dimensional echocardiography in assessment of cardiomyopathy.
    DeMaria AN; Bommer W; Lee G; Mason DT
    Am J Cardiol; 1980 Dec; 46(7):1224-31. PubMed ID: 6450529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall.
    Oki T; Tanaka H; Yamada H; Tabata T; Oishi Y; Ishimoto T; Nagase N; Shinohara H; Sakabe K; Fukuda N
    Am J Cardiol; 2004 Apr; 93(7):864-9. PubMed ID: 15050490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Echocardiographic evaluation of cardiac involvement in patients with chronic alcoholism].
    Houda N; Mori T; Takeuchi M; Yamamoto N; Morita N; Sugawa M; Nakano T; Takezawa H
    J Cardiogr; 1983 Sep; 13(3):551-70. PubMed ID: 6235296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hypertrophic cardiomyopathy--diagnostic significance of the disproportion of myocardial hypertrophy examined by two-dimensional echocardiography].
    Tomov I; Kutova Ts; Turnovska R
    Vutr Boles; 1988; 27(3):41-7. PubMed ID: 2974670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.